Gossamer Bio 10K 2021 Annual report | GOSS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: Aadi, accident, aforementioned, aggressive, Amsterdam, anesthesiology, Annex, Aranda, archived, Array, atrial, authorised, authoritative, backbone, BBB, BCR, beigene, Bioscience, blockade, boundary, brain, Bristol, Britain, Brukinsa, Bruton, calcium, Calquence, cardiovascular, Carter, Caryn, cautionary, Celegene, cerebrospinal, CHMP, clinician, clock, closure, CNS, Commissioner, constitutionality, contemplate, covalent, crossing, crystallized, CTA, database, delegated, Delta, derecognized, dialogue, discriminatory, dismissed, Donetsk, downstream, downturn, draft, EC, EGFR, embedded, England, evobrutinib, evolution, expiry, extracellular, FD, fenebrutinib, FeRx, fibrillation, float, forensic, GB, Great, harbor, Helsinki, hematologic, hematological, hematopoietic, ibrutinib, ID, image, Imbruvica, instructed, intracellular, invasion, laid, Laura, leave, left, Luhansk, Lycera, lymphoma, MAA, malignant, malware, Medimmune, mercaptopurine, methotrexate, MHRA, military, Milligan, modest, modestly, multidisciplinary, multifaceted, necessitate, neurological, neurotoxicity, nurse, obfuscate, Ono, opposed, orelabrutinib, ORR, paragraph, Parliament, partnership, PCNSL, PCSNL, Peterson, pharmacovigilance, pirtobrutinib, plc, polychemotherapy, principle, proactive, proportionality, radiographic, radiotherapy, ransomware, rapporteur, rash, reconsider, recurrent, reevaluation, reframing, relizabrutinib, relocation, remibrutinib, Richard, rilzabrutinib, RMP, Russian, safest, Sandra, Scotland, Secretary, slowdown, somwhat, spiked, streamline, suboptimal, summer, Syndax, tailored, TCA, TEC, textual, thought, titrate, tolebrutinib, transcription, transposed, Ukraine, unemployment, unintended, unlimited, unnecessary, vacated, vaccine, variant, variation, Velexbru, verity, vitreoretinal, voluntarily, watched, wholesale, worker, Wyeth

Removed: AA, Aberrant, Acceleron, adherence, adhesion, airflow, airway, allergic, allocating, AMT, antagonist, asthma, atopic, benralizumab, breast, bronchial, card, characterization, checkpoint, chemotherapy, Chiesi, Cinqair, cold, combine, comment, comparator, confirming, constriction, correlated, coughing, CRS, cytokine, cytotoxic, discontinued, disorder, dupilumab, Dupixent, electrocardiographic, eliminating, emerged, eosinophilic, esophageal, evasion, exam, exclusionary, expiratory, explore, Farmaceutici, Fasenra, fevipiprant, field, forfeiture, gastric, gather, Genentech, GlaxoSmithKline, Head, helper, holding, hyperactivity, ICS, Idorsia, immunologically, inappropriate, infiltration, influx, inseverable, integrin, intermittent, intrahepatic, IRS, Japanese, Judge, justified, Ki, LABA, Lake, liaison, lipid, liver, LP, lt, Luisa, mediating, medium, mepolizumab, microenvironment, montelukast, morning, nanomolar, nasal, Nucala, omalizumab, online, pancreatic, peak, PEF, pertaining, Pharma, phenotype, prescribe, presence, prominent, proportion, prostaglandin, prostate, Pulmagen, QS, qualifying, recapture, recruited, Regeneron, removed, repealed, repealing, replaced, rescue, residence, reslizumab, reversibly, revolutionized, rulemaking, Sanofi, shared, sputum, standardized, steroid, suggest, Suite, suppressive, suppressor, surgery, swelling, TEAE, Teijin, Teva, tezepelumab, thousand, TME, topical, toxicology, traceability, tumor, uncontrolled, urticaria, violating, visit, wheezing, white, Xolair

Gossamer Bio (GOSS) 10-K2021 FY Annual report

Content analysis